Skip to content
lifestyle.brickvest.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Vicore Pharma Holding
Vicore Pharma to Host Webcast to Discuss Buloxibutid and the Evolving IPF Treatment Landscape
June 2, 2026
Vicore Pharma to Present at the Jefferies Global Healthcare Conference
May 27, 2026
Vicore Pharma Pursues US Dual Listing, Files Registration Statement with the SEC
May 27, 2026
Vicore Pharma Elects Peter Guenter to its Board of Directors
May 25, 2026
Announcement from the Annual General Meeting of Vicore Pharma Holding AB (publ)
May 25, 2026
Interim Report January – March 2026
May 24, 2026
Vicore Pharma Announces Presentations at the 2026 American Thoracic Society International Conference
May 23, 2026
Vicore Pharma Completes Enrollment in the Phase 2b ASPIRE Trial of Buloxibutid in Idiopathic Pulmonary Fibrosis
May 22, 2026
Notice Of Annual General Meeting In Vicore Pharma Holding AB (PUBL)
May 19, 2026
Vicore Publishes the Annual Report for 2025
May 18, 2026
1
2
Next Page
→